Grifols, S.A. (GRFS)
NASDAQ·Healthcare·Drug Manufacturers - General
$8.08
-0.68%
Mkt Cap $7.41B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $2.34B | $2.34B | -0.20% | $0.29 | $0.29 | -0.31% | — | — |
| Q1 2026 Feb 25, 2026 | $1.97B | $2.34B | +18.99% | $0.29 | $0.30 | +2.10% | — | — |
| Q4 2025 Nov 4, 2025 | $2.15B | $2.18B | +1.49% | $0.24 | $0.22 | -9.60% | — | — |
| Q3 2025 Jul 28, 2025 | $1.86B | $2.23B | +19.77% | $0.23 | $0.19 | -17.39% | — | — |
| Q2 2025 May 12, 2025 | $1.73B | $1.96B | +13.13% | $0.14 | $0.10 | -28.57% | — | — |
| Q1 2025 Mar 6, 2025 | $1.92B | $2.05B | +6.49% | $0.13 | $0.26 | +100.00% | — | — |
| Q4 2024 Nov 7, 2024 | $2.03B | $1.97B | -3.15% | $0.22 | $0.16 | -27.27% | — | — |
| Q3 2024 Jul 30, 2024 | $1.88B | $1.95B | +3.96% | $0.23 | $0.02 | -91.30% | — | — |
| Q2 2024 May 14, 2024 | $1.96B | $1.76B | -10.05% | $0.15 | $0.07 | -53.33% | — | — |
| Q1 2024 Mar 5, 2024 | $1.91B | $1.95B | +1.65% | $0.22 | $0.14 | -36.36% | — | — |
| Q4 2023 Nov 2, 2023 | $1.68B | $1.69B | +0.15% | $0.22 | $0.11 | -50.00% | — | — |
| Q3 2023 Jul 27, 2023 | $1.85B | $1.81B | -2.17% | $0.20 | $0.09 | -54.80% | — | — |
| Q2 2023 May 16, 2023 | $1.69B | $1.68B | -0.61% | $0.16 | -$0.02 | -110.67% | — | — |
| Q1 2023 Mar 13, 2023 | — | $1.84B | — | $0.24 | $0.03 | -86.72% | — | — |
| Q1 2023 Feb 27, 2023 | — | $1.51B | — | $0.24 | $0.06 | -73.29% | — | — |
| Q3 2022 Jul 28, 2022 | $2.80B | $1.61B | -42.41% | $0.29 | $0.14 | -52.25% | — | — |
| Q1 2022 Feb 28, 2022 | $2.83B | $2.69B | -5.03% | $0.24 | -$0.13 | -155.08% | — | — |
| Q4 2021 Dec 30, 2021 | $1.58B | — | — | — | $0.36 | — | — | — |
| Q3 2021 Jul 29, 2021 | $3.00B | $1.60B | -46.50% | $0.27 | $0.35 | +29.63% | — | — |
| Q2 2021 May 4, 2021 | $1.46B | $1.39B | -4.29% | $0.22 | $0.21 | -5.96% | — | — |